Related Experiment Video
Updated: May 30, 2026
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Potential pathways to restore β-cell mass: pluripotent stem cells, reprogramming, and endogenous regeneration
Dana Baiu1, Fabiola Merriam, Jon Odorico
1Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health and WiCell Research Institute, Madison, WI, USA. baiu@surgery.wisc.edu
Current Diabetes Reports
|July 30, 2011
Summary
Current diabetes treatments like transplantation are limited by donor scarcity. New strategies focus on stem cells, regeneration, and cell reprogramming for beta-cell restoration, addressing diabetes cure challenges.
Area of Science:
- Endocrinology and Regenerative Medicine
- Immunology
Background:
- Current beta-cell replacement therapies (islet, pancreas transplantation) effectively restore glucose metabolism but face donor organ scarcity.
- This limitation restricts widespread application for diabetes treatment.
Purpose of the Study:
- To review emerging strategies for beta-cell mass restoration in diabetes.
- To highlight key challenges in translating these approaches for human application.
Main Methods:
- Review of recent scientific literature on beta-cell regeneration and replacement therapies.
- Analysis of strategies including stem cell-derived beta cells, endogenous regeneration, and cell reprogramming.
Main Results:
- Three primary strategies show promise: stem cell generation, endogenous regeneration stimulation, and non-beta cell reprogramming.
- Control of alloimmunity and autoimmunity is critical for allogeneic and syngeneic beta-cell therapies.
Conclusions:
- Novel beta-cell restoration strategies offer potential solutions to donor organ limitations.
- Overcoming immunological barriers and technical hurdles is essential for clinical translation in treating human diabetes.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...